Mar 7th 2019
Share This Post

Latest News - Out of the Gates February 2019

Pharmacists are intimately familiar with Valentine's Day, that recently passed mid-February holiday when the pharmacy's "seasonal" aisles become crowded with customers grabbing greeting cards and last-minute gifts for loved ones. 


All those heart-shaped boxes got me thinking of my love of pharmacy, and how that devotion to formulations is dependent on the professional relationships that I've formed -- particularly in the formative years of my career. 

I've been fortunate to connect with many like-minded colleagues, both near and far. Nationally, I've been active in the International Academy of Compounding Pharmacists, recently finishing my service on the board of the IACP Foundation.

The foundation just launched its Fund the Future program that supports travel grants for pharmacy students to attend two key industry conferences. These students may have already fallen in love with pharmacy while studying at school or interning on the bench, but their presence at the events can only make their hearts grow fonder.

Best wishes.



Ernest P. Gates Jr., RPh, FASCP, FIACP, FACA
President, Gates Healthcare Associates 
Donnie Calhoun Joins Gates Healthcare Team as Associate

Gates Healthcare is excited to welcome Donnie Calhoun, RPh, to its team of expert consultants.

As a new Associate, Calhoun brings decades of experience as a compounding pharmacist and association executive. He is the former CEO and Executive Vice President of the American College of Apothecaries (ACA) and has operated a compounding pharmacy in Alabama since 2012.

Gates Healthcare clients will benefit from Calhoun's insights into pharmacy practice, regulatory matters, professional education and business management.

From the Licensing Front

According to our partner LicenseLogix, the Missouri Board of Pharmacy now requires both resident and non-resident drug outsourcers and third-party logistics providers (3PLs) to have a Missouri drug outsourcer or 3PL license.
Prior to the change, 3PLs and drug outsourcers were required to hold a Missouri drug distributor license. The license change stems from amendments to Chapter 338 of the Missouri Revised Statutes (which can be viewed here).
The board requires 3PLs and drug outsourcing companies that currently hold a drug distributor license to convert their license to the appropriate category. Businesses that convert their license on or before March 1 will have the $300 application fee waived. Businesses engaged in both drug distribution and 3PL or drug outsourcing activities are required to hold both licenses. In addition, drug outsourcers must be registered with the U.S. FDA to be eligible for the new license. 
Have questions regarding the regulatory changes or need assistance filing for a license? Contact LicenseLogix by clicking here.
Healthy Headlines .....................................................

Below are several news stories on compounding and other pharmacy-related topics. Click on the headlines for more: